Wang Angela Yee-Moon, Sea Mandy Man-Mei, Ho Zoe So-Ying, Lui Siu-Fai, Li Philip Kam-Tao, Woo Jean
Department of Medicine and Therapeutics, Center for Nutritional Studies, Prince of Wales Hospital, Chinese University of Hong Kong, Shatin, Hong Kong.
Am J Clin Nutr. 2005 Jan;81(1):79-86. doi: 10.1093/ajcn/81.1.79.
Serum albumin has limitations as a nutritional marker in patients undergoing peritoneal dialysis (PD) in that it is affected by inflammation, systemic disease, overhydration, and urinary and dialysate protein loss. Handgrip strength is a simple, easily performed bedside test that has been shown to correlate with lean body mass in patients close to inception of dialysis.
We evaluated the associations of handgrip strength with other clinical factors and examined its relations with mortality and cardiovascular death in PD patients.
We prospectively enrolled 233 chronic PD patients and assessed handgrip strength and other variables at baseline and then followed the patients for a mean (+/-SD) of 30 +/- 14 mo.
Baseline handgrip strength was significantly associated with age, sex, height, diabetes, residual glomerular filtration rate (GFR), and hemoglobin but not with C-reactive protein (CRP). After adjustment for age, sex, and height, handgrip strength was most strongly correlated with lean body mass on the basis of creatinine kinetics (r = 0.334, P < 0.001), followed by serum albumin and subjective global assessment. Both men and women who died had lower handgrip strengths than did those who remained alive (P < 0.001). After control for age, sex, diabetes, atherosclerotic vascular disease, GFR, hemoglobin, CRP, and serum albumin, greater handgrip strength was predictive of lower all-cause [hazards ratio (HR): 0.95 (95% CI: 0.92, 0.99); P = 0.005] and cardiovascular [HR: 0.94 (0.90, 0.98); P = 0.004] mortality.
Handgrip strength not only is a marker of body lean muscle mass but also provides important prognostic information independent of other covariates, including CRP and serum albumin. Our data suggest that handgrip strength may be used in conjunction with serum albumin as a nutrition-monitoring tool in patients undergoing PD.
血清白蛋白作为腹膜透析(PD)患者的营养指标存在局限性,因为它会受到炎症、全身性疾病、水钠潴留以及尿液和透析液中蛋白质丢失的影响。握力是一项简单、易于在床边进行的测试,已被证明与透析开始时患者的瘦体重相关。
我们评估了握力与其他临床因素的关联,并研究了其与PD患者死亡率和心血管死亡的关系。
我们前瞻性纳入了233例慢性PD患者,在基线时评估握力和其他变量,然后对患者进行平均(±标准差)30±14个月的随访。
基线握力与年龄、性别、身高、糖尿病、残余肾小球滤过率(GFR)和血红蛋白显著相关,但与C反应蛋白(CRP)无关。在调整年龄、性别和身高后,基于肌酐动力学,握力与瘦体重的相关性最强(r = 0.334,P < 0.001),其次是血清白蛋白和主观全面评定。死亡的男性和女性的握力均低于存活者(P < 0.001)。在控制年龄、性别、糖尿病、动脉粥样硬化性血管疾病、GFR、血红蛋白、CRP和血清白蛋白后,握力越大预示全因死亡率越低[风险比(HR):0.95(95%CI:0.92,0.99);P = 0.005]和心血管死亡率越低[HR:0.94(0.90,0.98);P = 0.004]。
握力不仅是身体瘦肌肉量的标志物,还能提供独立于其他协变量(包括CRP和血清白蛋白)的重要预后信息。我们的数据表明,握力可与血清白蛋白联合用作PD患者的营养监测工具。